These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26064345)

  • 21. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of microRNA-218 and its clinicopathological and prognostic significance in human glioma cases.
    Cheng MW; Wang LL; Hu GY
    Asian Pac J Cancer Prev; 2015; 16(5):1839-43. PubMed ID: 25773834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
    Yang Y; Song KL; Chang H; Chen L
    Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue microRNA-182 expression level and its potential prognostic value for papillary thyroid carcinoma.
    Yao XG; Tan Q; Liu PP; Feng LJ
    Int J Clin Exp Pathol; 2019; 12(8):3128-3133. PubMed ID: 31934155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma.
    Niu J; Sun Y; Guo Q; Niu D; Liu B
    Springerplus; 2016; 5(1):1947. PubMed ID: 27917340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma.
    Jin W; Luo W; Fang W; Wang Y; Wang L; Shen Q; Liu W; Zhang H
    Pathol Res Pract; 2019 Jun; 215(6):152401. PubMed ID: 31014553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma.
    Mirghasemi A; Taheriazam A; Karbasy SH; Torkaman A; Shakeri M; Yahaghi E; Mokarizadeh A
    Cancer Cell Int; 2015; 15():86. PubMed ID: 26388701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological parameters and prognostic relevance of miR-21 and PTEN expression in Wilms' tumor.
    Cui M; Liu W; Zhang L; Guo F; Liu Y; Chen F; Liu T; Ma R; Wu R
    J Pediatr Surg; 2017 Aug; 52(8):1348-1354. PubMed ID: 28040201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma.
    Poukka M; Bykachev A; Siiskonen H; Tyynelä-Korhonen K; Auvinen P; Pasonen-Seppänen S; Sironen R
    BMC Cancer; 2016 May; 16():313. PubMed ID: 27184066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma.
    Wu S; Jia S; Xu P
    Int J Clin Exp Med; 2014; 7(12):5523-8. PubMed ID: 25664065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
    Wang K; Zhang ZW
    Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.
    Dai DL; Martinka M; Li G
    J Clin Oncol; 2005 Mar; 23(7):1473-82. PubMed ID: 15735123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma.
    Zhang L; Xiang P; Han X; Wu L; Li X; Xiong Z
    Int J Clin Exp Pathol; 2015; 8(9):11446-51. PubMed ID: 26617873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-153 expression and prognosis in non-small cell lung cancer.
    Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW
    Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma.
    Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):912-8. PubMed ID: 25199412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
    Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
    Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
    Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
    Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
    Wang Y; Dai DL; Martinka M; Li G
    Clin Cancer Res; 2007 Jul; 13(14):4111-6. PubMed ID: 17634537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
    Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.